Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - May 2014

PharmAccess Leaders Forum

19 May 2014 - 21 May 2014 - Paris, France

Bookmark and Share

NextLevel Pharma’s PharmAccess Leaders Forum is quickly becoming THE “must attend” event for senior representatives of the market access community in Europe. With over 30 senior-level speakers from Payers, HTAs, Hospitals, stakeholder groups, and not to mention the pharmaceutical industry, more than 100 participants will attend. Attendees will achieve the most relevant learning, benchmarking and networking experience available for senior executives who are involved in patient access, health economics, outcomes, pricing and reimbursement. 3 EVENTS IN ONE: 1. Innovative Pricing & Reimbursement Agreements 2. Achieving Market Access for High-Value Oncology Therapeutics 3. Best Practices in Economic Modeling to Demonstrate Superior Outcomes & Value This year’s “Spring Edition” in Paris, will focus the audience on the necessary steps to achieving rapid market access, through enhanced value-demonstration, whilst delivering as much certainty as possible for payers, as well as delivering the patient with the most innovative & beneficial products possible. Request agenda at or contact me directly for more information. We look forward to meeting you in Paris!

Further information
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos